“…Because substantial amounts of pure samples are required for further biological and clinical studies, a number of total syntheses of AGEs have been reported in the literature since the 1990s. Recent advances in the total syntheses of AGEs include mono-THF AGEs: murisolin (26) [90,91], longicin (27) [92,93], and cis-solamin (28) [94,95], adjacent bis-THF AGEs: bullatacin (14) [96], rolliniastatin 1 (7) [23,97], rollimembrin (29) [97,98], 10-hydroxyasimicin (30) [99,100], membranacin (31) [97,101], asimicin (15) [76,102], longimicin D (32) [103][104], and mucoxin (33) [105,106], non-adjacent bis-THF AGEs: cis-sylvaticin (34) [107,108] and gigantecin (9) [109,110], and others, jimenezin (35) [111,112], mucocin (36) [113,114], pyranicin (37) [115,116], pyragonicin (38) [115,117,118], rollicosin (18) [62,…”